USPH - U.S. Physical Thera... Stock Analysis | Stock Taper
Logo
U.S. Physical Therapy, Inc.

USPH

U.S. Physical Therapy, Inc. NYSE
$82.96 4.56% (+3.62)

Market Cap $1.26 B
52w High $93.50
52w Low $62.77
Dividend Yield 2.57%
Frequency Quarterly
P/E 35.00
Volume 171.97K
Outstanding Shares 15.20M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $202.73M $19.86M $-10.55M -5.2% $-0.44 $21.94M
Q3-2025 $164.02M $11.54M $7.24M 4.42% $0.48 $31.11M
Q2-2025 $164.18M $16.69M $8.81M 5.37% $0.58 $31.13M
Q1-2025 $152.55M $11.42M $9.9M 6.49% $0.8 $25.47M
Q4-2024 $180.45M $19.16M $7.44M 4.12% $0.52 $26.06M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $35.57M $1.2B $433.81M $476.43M
Q3-2025 $31.1M $1.2B $413.83M $503.57M
Q2-2025 $34.09M $1.18B $414.01M $500.75M
Q1-2025 $39.18M $1.18B $420.68M $497.26M
Q4-2024 $41.36M $1.17B $408.42M $488.93M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $5.61M $24.93M $-5.44M $-15.02M $4.47M $21.01M
Q3-2025 $17.64M $19.94M $-11.94M $-10.99M $-2.98M $15.63M
Q2-2025 $17.72M $34.86M $-12.71M $-27.25M $-5.1M $31.61M
Q1-2025 $9.9M $-4.67M $-6.63M $9.12M $-2.18M $-7.25M
Q4-2024 $12.49M $19.41M $-94.85M $-153K $-75.6M $16.92M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Net Patient Revenues
Net Patient Revenues
$150.00M $160.00M $160.00M $170.00M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
$30.00M $30.00M $30.00M $30.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at U.S. Physical Therapy, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

USPH combines a profitable core business with solid cash generation, moderate leverage, and adequate liquidity. It has a differentiated partnership model that keeps local leaders invested, a growing industrial injury prevention segment, expanding home-care capabilities, and emerging technology tools that improve efficiency. The national scale in a fragmented industry, plus alliances with hospitals and large employers, further reinforce its position. Overall, the financials and business model suggest a resilient, well-established platform.

! Risks

Key risks include heavy reliance on goodwill and intangible assets from acquisitions, which could be vulnerable if acquired practices underperform. The company operates with moderate debt and has been returning significant cash to shareholders, which reduces room for error if operating trends weaken. Industry-specific risks—reimbursement cuts, regulatory change, therapist supply constraints, and wage pressures—are ongoing concerns. The strategy also depends on successful integration of acquisitions, rollout of new clinics and technologies, and continued demand from employer clients for injury-prevention services.

Outlook

The outlook appears cautiously constructive. USPH has the ingredients for continued growth: a scalable partnership model, strong cash flow, room for additional acquisitions, and multiple growth vectors in industrial injury prevention, home-based care, and new clinics. At the same time, future performance will hinge on maintaining margin discipline, navigating reimbursement and labor headwinds, and ensuring that its innovation and technology efforts translate into real operational gains. With only one year of detailed data, long-term trends are not yet visible, so ongoing monitoring of growth, profitability, and balance-sheet quality is important to understand how the story evolves.